PTC Therapeutics Inc PTCT

US Biotechnology

$68.01 ▼ -9.94% ($-7.51)

⬇️ Below Yest. Low ⚡ High Volume

Open $70.92

Prev Close $75.52

Day Range $64.57 – $73.72

52W Range $43.18 – $90.87

Market Cap $5.64B

P/E (TTM) 792.55

Beta 0.55

EPS (TTM) $4.49

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2013-06-20
Shares Out.	82,950,000
Website	ptcbio.com/ ↗
Phone	13026365400
Employees	991
Revenue	$272.6M
Gross Profit	$244.5M
Net Income	-$2.8M
Free Cash Flow	-$226.3M
Total Assets	$2.87B
Total Liabilities	$3.05B
Equity	-$180.5M

About PTC Therapeutics Inc

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

PTC Therapeutics Inc is a publicly traded company under the ticker symbol PTCT on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.